Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.77 USD
-0.15 (-3.83%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $3.78 +0.01 (0.27%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Earnings News For STRO
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
-
Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
-
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
-
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
-
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
-
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
-
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Misses Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates
-
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy?
-
Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates
-
Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for
-
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates
-
Will Sutro Biopharma, Inc. (STRO) Report Negative Q2 Earnings? What You Should Know
-
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Lags Revenue Estimates
-
Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release